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Diabetes mellitus afflicts about 10 million Americans and
appears to be increasing at the rate of 6% per year. Bergman,
Ellison, and Dunea [1] initially reported the occurrence of acute
renal failure in a diabetic patient after infusion urography. Since
that time, at least 122 insulin-dependent (type 1) and maturity
onset (type 2) diabetic patients who developed deterioration of
renal function after contrast media study have been reported [1—
21]. Among these 122, 70 patients (57.3%) evidenced renal
dysfunction following intravenous urography (IVU). Sixty-four
(91%) of these 70 patients had a serum creatinine concentration
equal to or more than 2 rng/dl, while six had a level below 2
mg/dl before receiving contrast media. Of the other 52 diabetic
patients who developed renal failure following other contrast
media studies [aortography, selective angiography, intravenous
cholangiography, and CAT scanning] 12 (23%) had a serum
creatinine concentration less than 2 mg/dl prior to the study.
Thus, of 122 patients developing contrast media-induced renal
failure, 18 (15%) had serum creatinine concentrations below 2
mg/dl. A serum creatinine concentration of 2 mg/dl was selected
for analyzing prior reports to exclude minor creatinine eleva-
tions due to diuretics or transient dehydration.
To ascertain whether or not diabetic patients with apparent
good renal function face an increased risk of renal dysfunction
from exposure to contrast media, a prospective study was
performed in 49 type 2 diabetic patients with serum creatinine
less than 2 mgldl who were to undergo IVU.
Methods
Patient population. The study included 49 randomly selected
type 2 diabetic patients with a serum creatinine concentration
below 2 mg/dl who were admitted to the Diabetic Research
Hospital at the University of Alabama in Birmingham. Patients
ranged in age from 38 to 82 years (mean, 62 10 years). Twenty
(40%) were below 60 years, and twenty-nine (60%) were over 60
years old. There were 19 men and 30 women. Fifteen patients
had known of the diagnosis of diabetes mellitus for less than 5
years, while 16 had been diagnosed as diabetic for over 16
years. The mean age at diagnosis was 51 years (range, 35 to 73
years). Hypertension was noted in 38 (78%) patients; hyperten-
sive patients had a mean systolic pressure of 175 29 mm Hg
and a mean diastolic pressure of 89 19 mm Hg. All patients
were admitted for a comprehensive appraisal of their diabetic
status.
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Informed consent was obtained from patients after thorough
explanation of the objectives and risks of the study.
Study protocol. Day I: A fasting venous blood sample was
drawn for measurement of plasma glucose, serum creatinine,
and uric acid. Day 2: A 24-hr urine specimen was collected, and
an aliquot was taken for measurement of protein and creatinine.
Day 3: In preparation for IVU, patients were not dehydrated or
given a laxative, and were encouraged to drink water during the
night. They were allowed to drink water after midnight. The
IVU was performed in the morning, using 100 ml of sodium
diatrizoate 29.1%, and meglumine diatrizoate 28.5% (Renovist
IL®). The dye was administered intravenously over several
minutes.
Chemical testing of blood samples was performed on an
autoanalyzer with less than 5% variation in repeat measure-
ments of creatinine, urea nitrogen, and electrolytes. Serum
creatinine measurements were repeated 1, 3, and 6 days after
IVU. Deterioration of renal function was defined as a rise in the
serum creatinine concentration of at least 25%, or 0.5 mg/dl,
occurring within 48 hr after contrast media administration in the
absence of sepsis, hypotension, or other potential causes of
acute renal failure. A poststudy reduction in daily urinary
output to 400 ml or more was regarded as oliguria.
Results
Of 49 patients studied, three (6%) had an elevation of serum
creatinine concentration greater than 25% by day 3. One
patient, a 67-year-old white man with a 32-year history of
diabetes mellitus, developed oliguria on day 2; the oliguria
lasted 2 days. His serum creatinine concentration rose from 1.1
mg/dl before IVU to 3.2 mg/dl by day 3. One week post-IVU,
his serum creatinine fell to 1.9 mg/dl. Physical examination
disclosed peripheral sensory neuropathy, but no retinopathy
was detected on fluoroscein angiography. All other screening
biochemical tests were within normal limits. His creatinine
clearance was 74 ml/min, with only 29mg of urinary protein per
24 hr. His BP was 174/100mm Hg on the day of IVU study. The
patient had been treated with insulin in the past, but for the last
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3 years, he had been managed by diet alone achieving "good"
control of blood glucose concentration.
Post-IVU elevations in the serum creatinine concentration
were observed in two other men below the age of 60, each with
known diabetes for less than 5 years, within 3 days following
IVU (1.3 to 2.1, 1.2 to 2.1 mgldl, respectively). Neither man had
a history of hypertension. Physical examination in these two
men disclosed neither neuropathy nor retinopathy. All of their
biochemical tests were within normal limits. Their creatinine
clearances were 60 and 105 mllmin, respectively, prior to the
IVU study.
A comparison of the patients with post-IVU azotemia and
those without a serum creatinine rise is given in Table 1.
Although the renal failure group, consisting of three subjects, is
too small for statistical comparison, elevation in BP, uric acid,
and urine protein occurred more frequently in those without
evidence of renal dysfunction. The mean creatinine difference
in serum samples drawn before IVU, and one to three days
post-IVU in the three patients with renal dysfunction and the
other 46 patients without renal dysfunction are shown in Tables
2 and 3. Most patients (37 and 39 of 46) whose serum creatinine
concentrations were not elevated after IVU, had equal or lower
serum creatinine concentrations on the first or third day post-
IVU compared to their prestudy levels. All three with renal
dysfunction after IVU had an elevation of serum creatinine on
the first post-IVU day. The increase in serum creatinine was
significant, P <0.01 using the Fisher Exact Test.
Of 29 patients over age 60, 13 (45%) had a creatinine
clearance of less than 70 mI/mm (range, 36 to 69 ml/min), and
none had increased serum creatinine concentrations following
IVU. Of the 16 (55%) elderly patients who had a creatinine
clearance over 70 mI/mm (range, 70 to 194 ml/min), one
developed acute oliguric renal failure, although he had a creati-
nine clearance of 74 ml/min before IVU.
In the group of 20 patients under age 60, only two (10%) had a
creatinine clearance of less than 70 ml/min (45 and 60 mI/mm,
respectively). Of these "younger" diabetes mellitus patients,
one developed renal dysfunction following IVU. He had a
creatinine clearance of 60 mI/mm before IVU. Considering the
18 (37%) patients with creatinine clearance over 70 mI/mm
(range, 70 to 106 mllmin), only one exhibited an increase of
serum creatinine concentration after IVU. Proteinuria, defined
as more than 150 mg/24 hr, was present in nine patients, eight of
whom were hypertensive, and seven of whom were older than
68 years, but none developed post-IVU azotemia, The mean
creatinine clearance of the proteinuric group was 79.7 mI/mm
(range, 60 to 99 mllmin).
The serum creatinine concentration returned to a prestudy
level in all three patients who had shown a rise. None needed
dialysis.
Discussion
In the present report, three of 49 (6%) type 2 diabetic patients
developed renal dysfunction following intravenous urography
despite an absence of dehydration prior to contrast media
injection. Their serum creatinine concentrations were all below
1.3 mgldl, and their creatinine clearance was above 60 ml/min
before the study. Only one of these three became oliguric. After
2 days of oliguria a peak serum creatinine concentration of 3.2
mgldl was noted on day 3 post-IVU. The serum creatinine
Table 1. Clinical and laboratory data of 49 type 2 diabetes mellitus
studied by IVP
Patients with Patients without
renal dysfunction renal dysfunction
after IVP after IVP
Patient no. 3 46
Age, years 57 11 63 II
Sex, male 3 15
Onset of diabetes mellitus,
years of age 45 11 52 I
Duration of diabetes mellitus, 12 17 12 8
years (range, I to 32 years)
Retinopathy 0 4
Neuropathy 1 23
Hypertension 1 37
Serum uric acid, > 8 mgldl 0 8
Urine protein, 150 mg/24 hr 0 9
Creatinine clearance, mI/mm 79.6 23
(range, 60 to 105)
76.5 26
(range, 36 to 195)
Table 2. Comparison of mean serum creatinine concentration on first
post-IVP day and pre-study level in 49 type 2 diabetes mellitus
patientsa
Renal dysfunction
post-IVP
Yes No Total
Serum creatinine
P 1 day vs. prestudy 0
0 37 37
Serum creatinine
P 1 day vs. prestudy >0
3 9 12
Total 3 46 49
a P 0.011 with Fisher Exact Test.
Table 3. Comparison of serum creatinine concentration on third post-
IVP day and pre-study level in 49 type 2 diabetes mellitus patientsa
Renal dysfunc-
tion post-I VP
Yes No Total
Serum creatinine
P 3 days vs. prestudy 0
Serum creatinine
P 3 days vs. prestudy > 0
Total
0 39
3 7
3 46
39
10
49
a P 0.006 with Fisher Exact Test.
concentration in this patient returned to prestudy level in 2
weeks. This patient, who had been diabetic for 30 years, had
been hypertensive for more than 40 years, but no evidence of
nephropathy or retinopathy was detected on physical examina-
tion. Only two other patients evinced mild elevation of serum
creatinine (1.1 to 2.1 and 1.2 to 2.1 mg/dl, respectively) but did
not become oliguric. Their serum creatinine concentrations
returned to prestudy values within 1 week. No patient devel-
oped irreversible azotemia or oliguria.
Harkonen and Kjellstrand [20] reported four nonuremic dia-
betic patients who had an elevation of serum creatinine follow-
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Table 4. Renal dysfunction following IVP in nonuremic diabetes mellitus patients
Duration
of
diabetes
mellitus
Serum creatinine, mg/dl
Iodine
dosageBefore
Age Sex yr IVP Maximal Recovery Potential risk factors g Reference
57 F 10 1.9 5.5 4.7
Oliguria x 3 days
BP, 200/85 mm Hg
Diabetic microangiopathy
Urinary tract infection
Repeat IVU in I week
Dehydration
51.6 [12]
62 F 15 1.4 2.7 2.2
Oliguria x 2 days
BP, 160/95mm Hg
Diabetic microangiopathy
Dehydration
0.3 g/kg [6]
67 NA NA 1.8 NA NA Hypertension
Nephrolithiasis and unilateral
obstruction
Dehydration
42.3 [13]
81 NA NA 1.5 NA NA BPH with retention
Dehydration
Diuretic and antibiotics before
'VP
42.3 [13]
21 M 15 1.5 5.1 2.3 Diabetic microangiopathy
Proteinuria, 1.2 g/24 hr
Creatinine clearance, 50 mI/mm
NA [17]
NA NA NA 1.6 3.8 1.5 Juvenile onset diabetes with
long duration (?) 18 [20]
67 M 32 1.1 3.2 1.9
Oliguria x 2 days
BP, 174/100mm Hg
Diabetic neuropathy
31 Present
study
Abbreviations are: NA, not available; BPH, Benign prostatic hypertrophy.
ing IVU. Three of these four had proteinuria, and a serum
creatinine concentration of 1.6 to 1.8 mgldl before IVU. One of
these patients developed transient acute oliguric renal failure.
By contrast, none of our three patients had proteinuria, or prior
renal failure, although one, age 46, had a creatinine clearance of
60 mi/mm, indicating a mild degree of renal insufficiency. The
diagnosis of type 2 diabetes mellitus in these three patients is
substantiated by their regulation without insulin treatment, and
C-peptide values within normal limits.
Long duration diabetes mellitus has been proposed as a risk
factor for renal dysfunction following contrast media study [15].
Although two of the three patients had overt diabetes mellitus
for less than 5 years, it is not known whether or not these
patients had earlier undetected diabetes mellitus. The precise
timing of the onset of type 2 diabetes mellitus is often impossi-
ble. Previous reports refer to six diabetic patients who had post-
contrast media renal failure and whose serum creatinine level
was below 2 mg/dl [6, 12, 13, 17, 20]. At least three risk factors
might explain the occurrence, albeit rare, of acute renal failure
following IVU in diabetic patients with apparently normal renal
function prior to exposure to contrast media (Table 4). The first
relates to known abnormalities in diabetes mellitus. Diabetic
patients have high blood viscosity [22—26], which is greatest in
poorly controlled diabetes mellitus [23]. Hyperviscosity can
promote blood stasis in capillary and postcapillary venules [27—
291. Reduced blood flow in postcapillary venules may lead to
hypoxia, favoring formation of microthrombi [27, 28]. Blood
viscosity may be further increased by dehydration [23] or
infusion of hyperosmolar substances [30], including contrast
media. Fajers and Gelin [311 demonstrated that red cell aggrega-
tion following intravenous administration of an hyperosmolar
substance can cause necrosis of proximal tubular cells. Follow-
ing an injection of currently used contrast media, such as
diatrizoate, there may be a flattening and distortion in the shape
of red blood cells, changes which can increase blood viscosity
and can slow blood flow in posteapillary venules, causing renal
ischemia [32].
In small vessels, through which red cells pass in single file,
such as the afferent and efferent glomerular arterioles, erythro-
cytes must normally bend and deform in passage [33]. In
diabetes mellitus, erythrocyte deformability is reduced [221.
This impaired deformability can result in blood flow reduction
in the microcirculation causing renal ischemia. Erythrocyte
deformability is restricted further following infusion of contrast
media [34, 35].
Abnormal platelet aggregation [36, 37], might contribute to
the genesis of diabetic macro and microangiopathy [38]. Con-
trast media have been reported to reduce platelet aggregation
[39] while inhibiting clotting factors [40]. Recently, however,
Peterson and Gormsen [41] found no significant difference in
platelet aggregation between normal control persons and dia-
betic patients.
Arteriosclerosis of afferent and efferent glomerular vessels
could predispose to renal injury. Diffuse arterial intimal fibrosis
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Table 5. Possible risk factors in non-uremic diabetes mellitus patients
who developed renal failure following intravenous pyelography (IVP)
A. Primary underlying abnormalities:
I. Abnormal rheology
a. Hyperviscosity
b. Reduced deformability of red blood cell
c. Increased platelet aggregation
2. Diabetic artheriosclerosis and glomerulosclerosis
B. Contrast media-induced abnormalities:
a. Acute rheologic changes
b. Acute hemodynamic changes
c. Direct tubular toxicity
C. Secondary predisposing factors:
a. Dehydration
b. Hypertension
c. Repeated IVP in short period
is almost universal in diabetic patients after age 50 142].
Mogensen [43] reported that 83% of diabetic patients have
hyalinization of renal arterioles and interstitial fibrosis. Al-
though GFR is supranormal in type I diabetes mellitus [43],
once either constant proteinuria, or hypertensive arteriosclero-
sis develops, renal blood flow declines [40, 44, 45]. Superimpo-
sition of dehydration [46, 47] can reduce further renal cortical
blood flow accentuating renal ischemia, which, in turn, may
lead to acute tubular necrosis [48].
Evidence supporting the direct toxicity of contrast media to
renal tubules has been presented by Goldstein et al [49] who
demonstrated the presence of glutathione S-transferase (ligan-
din) in the urine samples of certain patients following renal
angiography. Soby and Hoy [50] also found a 50% decrease in
para-aminohippurate extraction in 20 consecutive patients un-
dergoing renal angiography, an observation confirmed by Dan-
ford, Tamer, and Davidson [51] in dogs. Gup et al [52] reported
decreased renal blood flow in three of ten nondiabetic patients
with normal renal function and filtration rate. Renal blood flow
fell in five of ten patients following intravenous administration
of 1 ml of 50% sodium diatrizoate per pound of body weight.
The effect of a similar dose of contrast media in diabetes
mellitus patients has not been studied.
Dehydration decreases cortical blood flow and increases
blood viscosity [46, 47]. Acute renal failure occurs more
frequently in patients dehydrated before IVU [5, 48]. Adequate
hydration does not always prevent acute renal failure [3, 6], as
shown in this study's patients.
Therefore, it is difficult to propose a specific level of renal
function at which procedures requiring administration of con-
trast media might be considered safe in diabetes mellitus
patients. This study of type 2 diabetes mellitus did not discern a
supranormal GFR (measured by endogenous creatinine clear-
ance) in either short- or long-term patients (unpublished data).
The absolute risk of an IVU in a type 2 diabetic patient who is
neither dehydrated nor azotemic is probably small. In this
study, 8 of 16 patients who had diabetes mellitus for longer than
15 years with reduced creatinine clearances below 70 mI/mm
(range, 36 to 69 mI/mm), withstood IVU without subsequent
azotemia or oliguria (Table 4). As a first guideline, it might be
suggested that type 2 diabetic patients with creatinine clear-
ances greater than 35 ml/min can be subjected safely to the
amount of contrast medium given in IVU, providing they do not
have other concomitant abnormality, such as proteinuria great-
er than 2 g124 hr. Repeated contrast medium exposure may pose
a cumulative risk if performed over several days [12].
In conclusion, contrast medium administration for intrave-
nous urography in type 2 diabetes mellitus will induce revers-
ible renal dysfunction in 6% of patients whose serum creatinine
concentration is below 2 mg/dl. IVU in a well hydrated nonazo-
temic diabetic patient is considered to be safe. The pathogene-
sis of the small incidence of acute renal failure in this subset of
diabetics is unknown but may be related to basic underlying
abnormalities of diabetes mellitus, advanced age, dehydration,
arteriosclerosis, and the subsequent alteration of blood viscosi-
ty induced by hyperosmolar contrast media [53].
Summary. The risk of developing contrast media-induced
acute renal failure was studied in 49 randomly selected nonazo-
temic type 2 adult diabetic patients subjected to IVU. There
were 19 men and 30 women in the group whose mean age was 62
10 years (range, 38 to 82 years). In preparation for IVU,
patients were neither dehydrated nor given a laxative. The IVU
was performed in the morning, using sodium diatrizoate and
meglumine diatrizoate. Serum creatinine levels were measured
pre-IVU and on days 1, 3, and 6 after the IVU. A total of three
patients (6%) had an elevation of serum creatinine greater than
25% above the baseline by post-IVU day 3. One patient
developed oliguria (<400 ml/24 hr) that lasted 2 days. Creati-
nine clearances of the three patients showing contrast media
toxicity were 74, 60, and 105 mI/mm pre-IVU. In each of the
three patients, a return to pre-IVU serum creatinine concentra-
tion was noted within 2 weeks. It is concluded that the risk of
acute renal failure post-IVU is small in hydrated nonazotemic
type 2 diabetic patients.
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